SCA
ABBV icon

Stillwater Capital Advisors’s AbbVie ABBV Stock Holding History

Stillwater Capital Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.5M Sell
89,325
-175
-0.2% -$37.7K 2.29% 17
2026
Q1 		$19.5M Sell
89,500
-1,126
-1% -$250K 2.22% 19
2025
Q4 		$20.7M Buy
90,626
+115
+0.1% +$26.2K 2.23% 17
2025
Q3 		$21M Sell
90,511
-369
-0.4% -$75.1K 2.36% 16
2025
Q2 		$16.9M Buy
90,880
+273
+0.3% +$50.7K 2.15% 20
2025
Q1 		$19M Sell
90,607
-209
-0.2% -$40.6K 2.65% 13
2024
Q4 		$16.1M Buy
90,816
+1,018
+1% +$187K 2% 21
2024
Q3 		$17.7M Sell
89,798
-989
-1% -$185K 2.29% 18
2024
Q2 		$15.6M Sell
90,787
-667
-0.7% -$110K 2.17% 19
2024
Q1 		$16.7M Buy
91,454
+78
+0.1% +$13.4K 2.47% 15
2023
Q4 		$14.2M Sell
91,376
-279
-0.3% -$40.7K 2.27% 18
2023
Q3 		$13.7M Buy
+91,655
New +$13.5M 2.49% 14
2016
Q2 		– Sell
-195,364
Closed -$11.2M – 77
2016
Q1 		$11.2M Sell
195,364
-299
-0.2% -$16.7K 3.3% 7
2015
Q4 		$11.6M Sell
195,663
-3,965
-2% -$228K 3.55% 8
2015
Q3 		$10.9M Buy
199,628
+373
+0.2% +$24.3K 3.71% 6
2015
Q2 		$13.4M Buy
199,255
+1,444
+0.7% +$94.3K 3.87% 2
2015
Q1 		$11.6M Buy
197,811
+4,473
+2% +$270K 3.52% 6
2014
Q4 		$12.7M Buy
193,338
+7,666
+4% +$483K 3.8% 4
2014
Q3 		$10.7M Buy
185,672
+2,400
+1% +$133K 3.58% 4
2014
Q2 		$10.3M Buy
183,272
+24,084
+15% +$1.26M 3.52% 6
2014
Q1 		$8.18M Buy
+159,188
New +$8.05M 2.97% 19

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Stillwater Capital Advisors's ABBV Position: Q2 2026 in Review

Stillwater Capital Advisors reduced its AbbVie (ABBV) stake by 0.2% in Q2 2026, selling an estimated $37.7K and leaving 89,325 shares worth $22.5M. The position accounts for 2.29% of the portfolio, ranked #17.

Stillwater Capital Advisors first reported a position in ABBV in Q1 2014 and has held it in 21 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Stillwater Capital Advisors held 89,325 shares of AbbVie worth $22.5M as of Q2 2026.
  • Stillwater Capital Advisors sold 175 AbbVie shares in Q2 2026, an estimated $37.7K.
  • AbbVie made up 2.29% of Stillwater Capital Advisors's portfolio in Q2 2026, its #17 holding.
  • Stillwater Capital Advisors first reported a position in AbbVie in Q1 2014 and has held it in 21 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Stillwater Capital Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.